MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3324/haematol.2022.281510

Медицинская библиотека · Haematologica · 2023

Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma.

Kameda Takuro, Kataoka Keisuke, Kamiunten Ayako, Hidaka Michihiro, Miyoshi Hiroaki, Nakano Nobuaki, Nosaka Kisato, Yoshimitsu Makoto, Yasunaga Jun-Ichirou, Kogure Yasunori, Shide Kotaro, Miyahara Masaharu, Sakamoto Takashi, Akizuki Keiichi, Hidaka Tomonori, Kubuki Yoko, Koya Junji, Kawano Noriaki, Yamashita Kiyoshi, Kawano Hiroshi, Toyama Takanori, Maeda Kouichi, Marutsuka Kosuke, Imaizumi Yoshitaka, Kato Koji, Sugio Takeshi, Tokunaga Masahito, Tashiro Yukie, Takaori-Kondo Akifumi, Miyazaki Yasushi, Akashi Koichi, Ishitsuka Kenji, Matsuoka Masao, Ohshima Koichi, Watanabe Toshiki, Kitanaka Akira, Utsunomiya Atae, Ogawa Seishi, Shimoda Kazuya

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

The prognosis of aggressive adult T-cell leukemia/lymphoma (ATL) is poor, and allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment. In order to identify favorable prognostic patients after intensive chemotherapy, and who therefore might not require upfront allo-HSCT, we aimed to improve risk stratification of aggressive ATL patients aged <70 years. The clinical risk factors and genetic mutations were incorporated into risk modeling for overall survival (OS). We generated the m7-ATLPI, a clinicogenetic risk model for OS, that included the ATL prognostic index (PI) (ATL-PI) risk category, and non-silent mutations in seven genes, namely TP53, IRF4, RHOA, PRKCB, CARD11, CCR7, and GATA3. In the training cohort of 99 patients, the m7-ATLPI identified a low-, intermediate-, and highrisk group with 2-year OS of 100%, 43%, and 19%, respectively (hazard ratio [HR] =5.46; P<0.0001). The m7-ATLPI achieved superior risk stratification compared to the current ATL-PI (C-index 0.92 vs. 0.85, respectively). In the validation cohort of 84 patients, the m7-ATLPI defined low-, intermediate-, and high-risk groups with a 2-year OS of 81%, 30%, and 0%, respectively (HR=2.33; P=0.0094), and the model again outperformed the ATL-PI (C-index 0.72 vs. 0.70, respectively). The simplified m7-ATLPI, which is easier to use in clinical practice, achieved superior risk stratification compared to the ATLPI, as did the original m7-ATLPI; the simplified version was calculated by summing the following: high-risk ATL-PI category (+10), low-risk ATL-PI category (-4), and non-silent mutations in TP53 (+4), IRF4 (+3), RHOA (+1), PRKCB (+1), CARD11 (+0.5), CCR7 (-2), and GATA3 (-3).

Для цитирования: Kameda Takuro, Kataoka Keisuke, Kamiunten Ayako, Hidaka Michihiro, Miyoshi Hiroaki, Nakano Nobuaki, Nosaka Kisato, Yoshimitsu Makoto, Yasunaga Jun-Ichirou, Kogure Yasunori, Shide Kotaro, Miyahara Masaharu, Sakamoto Takashi, Akizuki Keiichi, Hidaka Tomonori, Kubuki Yoko, Koya Junji, Kawano Noriaki, Yamashita Kiyoshi, Kawano Hiroshi, Toyama Takanori, Maeda Kouichi, Marutsuka Kosuke, Imaizumi Yoshitaka, Kato Koji, Sugio Takeshi, Tokunaga Masahito, Tashiro Yukie, Takaori-Kondo Akifumi, Miyazaki Yasushi, Akashi Koichi, Ishitsuka Kenji, Matsuoka Masao, Ohshima Koichi, Watanabe Toshiki, Kitanaka Akira, Utsunomiya Atae, Ogawa Seishi, Shimoda Kazuya. Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma.. Haematologica. 2023. DOI: 10.3324/haematol.2022.281510.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.